Shin Nippon Biomedical Laboratories, Ltd. (OTCMKTS:SBLOF) Short Interest Down 78.8% in June

Shin Nippon Biomedical Laboratories, Ltd. (OTCMKTS:SBLOF) was the target of a large decline in short interest during the month of June. As of June 30th, there was short interest totaling 19,501 shares, a decline of 78.8% from the June 15th total of 91,883 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is currently ∞ days.

Shin Nippon Biomedical Laboratories Price Performance

SBLOF stock remained flat at $7.00 during trading hours on Friday. Shin Nippon Biomedical Laboratories has a 52 week low of $7.00 and a 52 week high of $9.16. The business has a fifty day moving average of $8.12 and a two-hundred day moving average of $9.22.

About Shin Nippon Biomedical Laboratories

Shin Nippon Biomedical Laboratories, Ltd. (OTCMKTS: SBLOF) is a Japan‐based contract research organization specializing in nonclinical safety assessment for the pharmaceutical, biotechnology and agrochemical industries. Established in 1978 and headquartered in Kagoshima, the company provides a range of preclinical testing services designed to support drug development from early discovery through regulatory submission. SBLOF is known for its adherence to Good Laboratory Practice (GLP) standards and its focus on high‐quality data generation and compliance.

The company’s core services include toxicology studies, pharmacokinetics and bioanalysis, safety pharmacology, pathology and genetic toxicology.